Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Moderna Inc. buy Ellritze

Start price
€137.00
22.01.22 / 70%
Target price
€165.00
22.01.23
Performance (%)
4.37%
End price
€142.98
06.02.22
Summary
This prediction ended on 06.02.22 with a price of €142.98. With a performance of 4.37%, the BUY prediction by Ellritze for Moderna Inc. closed with a slight gain. Ellritze has 70% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Moderna Inc. 8.232% 8.232% -25.594%
iShares Core DAX® 2.149% 5.415% 21.385%
iShares Nasdaq 100 0.838% 1.926% 44.386%
iShares Nikkei 225® 1.143% 2.887% 27.641%
iShares S&P 500 1.265% 3.698% 33.327%

According to Ellritze what are the pros and cons of Moderna Inc. for the foreseeable future?

Pros
Revenue growth >5% per year expected
Differentiated customer and product portfolio
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Cons
Higher risks for its business
Below average Marketposition

Comments by Ellritze for this prediction

In the thread Moderna Inc. diskutieren
Prediction Buy
Perf. (%) 4.37%
Target price 165.000
Change
Ends at 22.01.23

Buy mit Kursziel 165,0

In the thread Trading Moderna Inc.
Prediction Buy
Perf. (%) 4.37%
Target price 165.000
Change
Ends at 22.01.23

Buy beendet

Stopped prediction by Ellritze for Moderna Inc.

buy
Moderna Inc.

Start price
Target price
Perf. (%)
€158.84
04.04.22
€178.00
04.04.23
-12.49%
19.04.22

Revenue growth >5% per year expected
Differentiated customer and product portfolio
Future proof or reliable business model
Higher risks for its business
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€162.42
21.03.22
€180.00
21.03.23
-2.20%
04.04.22

Revenue growth >5% per year expected
Differentiated customer and product portfolio
Future proof or reliable business model
Higher risks for its business
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€139.80
21.01.22
€160.00
21.01.23
-2.00%
22.01.22

Revenue growth >5% per year expected
Differentiated customer and product portfolio
Future proof or reliable business model
Higher risks for its business
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€224.75
25.12.21
€260.00
25.12.22
-14.41%
06.01.22

Revenue growth >5% per year expected
Differentiated customer and product portfolio
Future proof or reliable business model
Higher risks for its business
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€232.00
12.12.21
€260.00
12.12.22
-3.13%
25.12.21

Revenue growth >5% per year expected
Differentiated customer and product portfolio
Future proof or reliable business model
Higher risks for its business
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€274.00
01.12.21
€260.00
01.12.22
-15.33%
12.12.21

Revenue growth >5% per year expected
Differentiated customer and product portfolio
Future proof or reliable business model
Higher risks for its business